Seeking Alpha

After reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its...

After reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its Lifecodes business unit to Immucor (BLUD). Under the terms, HOLX will receive $85M in cash at closing and have the opportunity to earn a contingent payment of $10M based on achievement of certain financial targets throughout 2013. The transaction is expected to close during Q2.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector